Concerted regulation of OPG/RANKL/ NF‑κB/MMP-13 trajectories contribute to ameliorative capability of prodigiosin and/or low dose γ-radiation against adjuvant- induced arthritis in rats

• Published in: International immunopharmacology 2022-10, Vol.111, p.109068-109068, Article 109068
• Main Authors: Abdel-Rafei, Mohamed K., Thabet, Noura M., Amin, Mohamed M.
• Format: Article
• Language: English
• Subjects: AIA; Low dose radiation; MMP-13, NF-κB; OPG/RANKL; Prodigiosin
• ISSN: 1567-5769; 1878-1705
• DOI: 10.1016/j.intimp.2022.109068

•Rheumatoid arthritis (RA) is a prevalent long-term autoimmune inflammatory disorder, ultimately leading to joint obliteration.•Prodigiosin (PDG), a microbial dye, exerted prominent anti-inflammatory and anti-arthritic effects.•Low dose γ-radiation (LDR) in a split doses strategy alleviated the severity of arthritic symptoms.•PDG and/or LDR efficiently regulated OPG/RANKL/ NF ‑ κB/MMP-13 signaling and prevented osteoclastogenesis as well as bone erosion.•PDG and/or LDR improved histopathological lesions in arthritic joints. Prodigiosin (PDG) is a microbial red dye with antioxidant and anti-inflammatory properties, although its effect on rheumatoid arthritis (RA) remains uncertain. Also, multiple doses of low dose γ- radiation (LDR) have been observed to be as a successful intervention for RA. Thus, the purpose of this study was to investigate the ameliorative potential of PDG and/or LDR on adjuvant-induced arthritis (AIA) in rats. The anti-inflammatory and anti-arthritic effects of PDG and/or LDR were examined in vitro and in vivo, respectively. In the AIA model, the arthritic indexes, paw swelling degrees, body weight gain, and histopathological assessment in AIA rats were assayed. The impact of PDG (200 µg/kg; p.o) and/or LDR (0.5 Gy) on the levels of pro- and anti-inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-18, IL-17A, and IL-10) as well as the regulation of osteoprotegrin (OPG)/ receptor activator of nuclear factor κB ligand (RANKL)/ nuclear factor-κB (NF-κB)/MMP-13 pathways was determined. Methotrexate (MTX; 0.05 mg/kg; twice/week, i.p) was administered concurrently as a standard anti-arthritic drug. PDG and/or LDR markedly diminished the arthritic indexes, paw edema, weigh loss in AIA rats, alleviated the pathological alterations in joints, reduced the levels of pro-inflammatory cytokines IL-1β, TNF-α, IL-6, IL-18, IL-17A, and RANKL in serum and synovial tissues, while increasing anti-inflammatory cytokines IL-10 and OPG levels. Moreover, PDG and/or LDR down-regulated the expression of RANKL, NF-κBp65, MMP13, caspase-3, and decreased the RANKL/OPG ratio, whereas OPG and collagen II were enhanced in synovial tissues. PDG and/or LDR exhibited obvious anti-RA activity on AIA.